These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 31787692

  • 1. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H, Yasuda S, Kakoi S, Ohata Y, Shimizu Y, Hasegawa C, Hayakawa A, Akiyama T, Yagi T, Aotani D, Imaeda K, Ozono K, Kataoka H, Tanaka T.
    Intern Med; 2020 Mar 15; 59(6):811-815. PubMed ID: 31787692
    [Abstract] [Full Text] [Related]

  • 2. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 3. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 4. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 16; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 5. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 16; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR.
    Osteoporos Int; 2019 Sep 16; 30(9):1713-1722. PubMed ID: 30915507
    [Abstract] [Full Text] [Related]

  • 7. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Feb 16; 29(2):511-515. PubMed ID: 29046930
    [Abstract] [Full Text] [Related]

  • 8. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 16; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 9. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ.
    BioDrugs; 2016 Feb 16; 30(1):41-8. PubMed ID: 26832358
    [Abstract] [Full Text] [Related]

  • 10. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct 16; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 11. Enzyme Replacement Therapy in Hypophosphatasia.
    Uçaktürk SA, Elmaogullari S, Ünal S, Gönülal D, Mengen E.
    J Coll Physicians Surg Pak; 2018 Sep 16; 28(9):S198-S200. PubMed ID: 30173697
    [Abstract] [Full Text] [Related]

  • 12. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.
    Freitas TQ, Franco AS, Pereira RMR.
    Medicine (Baltimore); 2018 Nov 16; 97(48):e13210. PubMed ID: 30508901
    [Abstract] [Full Text] [Related]

  • 13. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia.
    Ogawa E, Shimura K, Yoshihashi H, Miyama S.
    Pediatr Neurol; 2022 May 16; 130():4-6. PubMed ID: 35303588
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review.
    Shirinezhad A, Esmaeili S, Azarboo A, Tavakoli Y, Hoveidaei AH, Zareshahi N, Ghaseminejad-Raeini A.
    Bone; 2024 Nov 16; 188():117219. PubMed ID: 39089608
    [Abstract] [Full Text] [Related]

  • 15. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.
    Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K.
    Eur J Pediatr; 2016 Mar 16; 175(3):433-7. PubMed ID: 26459154
    [Abstract] [Full Text] [Related]

  • 16. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Sep 16; 29(9):2155-2156. PubMed ID: 29967930
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry.
    Kishnani PS, Martos-Moreno GÁ, Linglart A, Petryk A, Messali A, Fang S, Rockman-Greenberg C, Ozono K, Högler W, Seefried L, Dahir KM.
    Orphanet J Rare Dis; 2024 Mar 08; 19(1):109. PubMed ID: 38459585
    [Abstract] [Full Text] [Related]

  • 18. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr 08; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 19. Impressive clinical improvement and disappearance of neuropathic pain in an adult patient with hypophosphatasia treated with asfotase alfa.
    Zervou Z, Plooij R, van Velsen EFS, Timmermans RGM, Demirdas S, Zillikens MC.
    Eur J Med Genet; 2024 Apr 08; 68():104915. PubMed ID: 38325645
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia.
    Pan WJ, Pradhan R, Pelto R, Seefried L.
    J Clin Pharmacol; 2021 Oct 08; 61(10):1334-1343. PubMed ID: 33822385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.